Polyclonal Immunoglobulin G N-Glycosylation in the Pathogenesis of Plasma Cell Disorders.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Proteome Research

• Publication date

  2017-02-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/acs.jproteome.6b00768PMID 27936757
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Emerging Importance of IgG Fab Glycosylation in Immunity

  2016cited by this paper
• The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins

  2016cited by this paper
• Fc-galactosylation modulates antibody-dependent cellular cytotoxicity of therapeutic antibodies.

  2016cited by this paper
• IgG Glycome in Colorectal Cancer

  2016cited by this paper
• limma powers differential expression analyses for RNA-sequencing and microarray studies

  2015cited by this paper
• Fc glycans of therapeutic antibodies as critical quality attributes

  2015cited by this paper
• In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity

  2015cited by this paper
• Association of Systemic Lupus Erythematosus With Decreased Immunosuppressive Potential of the IgG Glycome

  2015cited by this paper
• Inflammatory Bowel Disease Associates with Proinflammatory Potential of the Immunoglobulin G Glycome

  2015cited by this paper
• Symbol Nomenclature for Graphical Representations of Glycans.

  2015cited by this paper
• A method for high-throughput, sensitive analysis of IgG Fc and Fab glycosylation by capillary electrophoresis.

  2015cited by this paper
• Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins.

  2015cited by this paper
• Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies

  2014cited by this paper
• International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

  2014cited by this paper
• Immunoglobulin G (IgG) Fab Glycosylation Analysis Using a New Mass Spectrometric High-throughput Profiling Method Reveals Pregnancy-associated Changes*

  2014cited by this paper
• IgG Subclasses and Allotypes: From Structure to Effector Functions

  2014cited by this paper
• Comparative Performance of Four Methods for High-throughput Glycosylation Analysis of Immunoglobulin G in Genetic and Epidemiological Research

  2014cited by this paper
• Influence of glycosylation pattern on the molecular properties of monoclonal antibodies

  2014cited by this paper
• Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

  2014cited by this paper
• The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma.

  2014cited by this paper
• The Glycome of Normal and Malignant Plasma Cells

  2013cited by this paper
• Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers

  2013cited by this paper
• The role of Fc receptors and complement in autoimmunity.

  2013cited by this paper
• High-throughput IgG Fc N-glycosylation profiling by mass spectrometry of glycopeptides.

  2013cited by this paper
• The Systemic Cytokine Environment Is Permanently Altered in Multiple Myeloma

  2013cited by this paper
• Differential chemical derivatization integrated with chromatographic separation for analysis of isomeric sialylated N-glycans: a nano-hydrophilic interaction liquid chromatography-MS platform.

  2013cited by this paper
• Chemical and Structural Analysis of an Antibody Folding Intermediate Trapped during Glycan Biosynthesis

  2012cited by this paper
• A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance.

  2012cited by this paper
• High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations

  2011cited by this paper
• Multiplexed analytical glycomics: rapid and confident IgG N-glycan structural elucidation.

  2011cited by this paper
• Ultra performance liquid chromatographic profiling of serum N-glycans for fast and efficient identification of cancer associated alterations in glycosylation.

  2010cited by this paper
• Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

  2010cited by this paper
• A framework for oligonucleotide microarray preprocessing

  2010cited by this paper
• Glycoproteomic analysis of abnormal N-glycosylation on the kappa chain of cryocrystalglobulin in a patient of multiple myeloma

  2009cited by this paper
• A SNP microarray and FISH‐based procedure to detect allelic imbalances in multiple myeloma: An integrated genomics approach reveals a wide gene dosage effect

  2009cited by this paper
• Increasing the sialylation of therapeutic glycoproteins: the potential of the sialic acid biosynthetic pathway.

  2009cited by this paper
• Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

  2009cited by this paper
• HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software.

  2008cited by this paper
• Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc

  2008cited by this paper
• Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma.

  2007cited by this paper
• AbnormalN-Glycosylation of the Immunoglobulin G κ Chain in a Multiple Myeloma Patient with Crystalglobulinemia: Case Report

  2007cited by this paper
• Contrasting glycosylation profiles between Fab and Fc of a human IgG protein studied by electrospray ionization mass spectrometry.

  2007cited by this paper
• Aberrant glycosylation of Igg heavy chain in multiple myeloma.

  2007cited by this paper
• Enhanced binding affinity for FcgammaRIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity.

  2007cited by this paper
• FcRn: the neonatal Fc receptor comes of age

  2007cited by this paper
• High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G.

  2006cited by this paper
• Nonfucosylated Therapeutic IgG1 Antibody Can Evade the Inhibitory Effect of Serum Immunoglobulin G on Antibody-Dependent Cellular Cytotoxicity through its High Binding to FcγRIIIa

  2006cited by this paper
• Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.

  2006cited by this paper
• Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma

  2005cited by this paper
• affy - analysis of Affymetrix GeneChip data at the probe level

  2004cited by this paper
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity*

  2002cited by this paper
• A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

  2002cited by this paper
• Increased sialylation of oligosaccharides on IgG paraproteins--a potential new tumour marker in multiple myeloma.

  1998cited by this paper
• Glycosylation of polyclonal and paraprotein IgG in multiple myeloma

  1997cited by this paper
• Interaction of aglycosyl immunoglobulins with the IgG Fc transport receptor from neonatal rat gut: comparison of deglycosylation by tunicamycin treatment and genetic engineering.

  1992cited by this paper
• Carbohydrate analysis of immunoglobulin G myeloma proteins by lectin and high performance liquid chromatography: role of glycosyltransferases in the structures.

  1990cited by this paper
• A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins.

  1990cited by this paper

• The importance of IgG N-glycosylation in Health, Disease, and Neonatal hemochromatosis

  2025cites this paper
• Antibody glycosylation in neuroimmune diseases

  2025cites this paper
• B4GALT3 as a Key Glycosyltransferase Gene in Multiple Myeloma Progression: Insights From Bioinformatics, Machine Learning, and Experimental Validation

  2025cites this paper
• Post-Translational Modifications in Multiple Myeloma: Mechanisms of Drug Resistance and Therapeutic Opportunities

  2025cites this paper
• The Human Blood N-Glycome: Unraveling Disease Glycosylation Patterns

  2024cites this paper
• IgG Glycosylation: Biomarker, Functional Modulator, and Structural Component.

  2024cites this paper
• The role of antibody glycosylation in autoimmune and alloimmune kidney diseases

  2024cites this paper
• Host glycosylation of immunoglobulins impairs the immune response to acute Lyme disease

  2024cites this paper
• IgG N-glycan Signatures as Potential Diagnostic and Prognostic Biomarkers

  2023cites this paper
• Direct Mass Spectrometry-Based Detection and Antibody Sequencing of Monoclonal Gammopathy of Undetermined Significance from Patient Serum: A Case Study

  2023cites this paper
• IgG glycans in health and disease: Prediction, intervention, prognosis, and therapy.

  2023cites this paper
• Comprehensive bioinformatics analysis reveals the hub genes and pathways associated with multiple myeloma

  2022cites this paper
• Hydrophilic interaction liquid chromatography-mass spectrometry for the characterization of glycoproteins at the glycan, peptide, subunit, and intact level

  2021cites this paper
• Identification of novel combined biomarkers in the diagnosis of multiple myeloma

  2021cites this paper
• Immunoglobulin G Glycosylation in Diseases.

  2021cites this paper
• Systems Glycobiology: Immunoglobulin G Glycans as Biomarkers and Functional Effectors in Aging and Diseases

  2021cites this paper
• Sialylated Immunoglobulins for the Treatment of Immuno-Inflammatory Diseases

  2020cites this paper
• Proteomics-inspired precision medicine for treating and understanding multiple myeloma

  2020cites this paper
• Monoclonal immunoglobulins promote bone loss in multiple myeloma.

  2020cites this paper
• Перспективы использования сиалированных иммуноглобулинов в терапии различных заболеваний

  2020cites this paper
• Prospects for the use of sialylated immunoglobulins in the treatment of different diseases

  2020cites this paper
• ИСПОЛЬЗОВАНИЯ СИАЛИРОВАННЫХ ИММУНОГЛОБУЛИНОВ В ТЕРАПИИ РАЗЛИЧНЫХ ЗАБОЛЕВАНИЙ PROSPECTS FOR THE USE OF SIALYLATED IMMUNOGLOBULINS IN DISEASE TREATMENT

  2020cites this paper
• An interactive online resource for characterizing molecular phenotypes 1 across hematologic malignancies 2

  2019cites this paper
• Hemap: An Interactive Online Resource for Characterizing Molecular Phenotypes across Hematologic Malignancies.

  2019cites this paper
• Serum protein N-glycosylation changes in multiple myeloma.

  2019cites this paper
• Current and future biomarkers for risk-stratification and treatment personalisation in multiple myeloma.

  2019cites this paper
• Hydrophilic interaction chromatography for the analysis of biopharmaceutical drugs and therapeutic peptides: A review based on the separation characteristics of the hydrophilic interaction chromatography phases.

  2019cites this paper
• IgG Fc N-glycosylation: Alterations in neurologic diseases and potential therapeutic target?

  2019cites this paper
• Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms

  2018cites this paper
• Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions

  2018cites this paper
• IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids.

  2018cites this paper
• Analyzing protein glycosylation using UHPLC: a review.

  2018cites this paper
• Immunoglobulin G glycosylation in aging and diseases.

  2018cites this paper
• High β-1,4-Galactosyltransferase-I expression in peripheral T-lymphocytes is associated with a low risk of relapse in germ-cell cancer patients receiving high-dose chemotherapy with autologous stem cell reinfusion

  2018cites this paper
• Proteomic and glycomic analyses of the potential protective role of zeolite on an osteoporotic rat model

  2018cites this paper
• Pro-inflammatory State in Monoclonal Gammopathy of Undetermined Significance and in Multiple Myeloma Is Characterized by Low Sialylation of Pathogen-Specific and Other Monoclonal Immunoglobulins

  2017cites this paper
• Affinity chromatography on monolithic supports for simultaneous and high‐throughput isolation of immunoglobulins from human serum

  2017cites this paper
• N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma

  2017cites this paper
• A Generic HPLC Method for Absolute Quantification of Oxidation in Monoclonal Antibodies and Fc-Fusion Proteins Using UV and MS Detection.

  2017cites this paper